Video capsule endoscopy compared with standard endoscopy for the evaluation of small-bowel polyps in persons with familial adenomatous polyposis (with video)

Wong, Robert F.; Tuteja, Ashok K.; Haslem, Derrick S.; Pappas, Lisa M.; Szabó, Anikó; Ogara, Maydeen M.; DiSario, James A.

doi:10.1016/j.gie.2005.12.014

Cited by 85 publications

(64 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…CE underestimates the number of SB polyps and does not reliably detect large polyps [61] . Technical problems related to the battery and failure of image downloading are also reported.…”

Section: Complications Limitations and Safety Issues Of Capsule Endomentioning

confidence: 99%

See 1 more Smart Citation

Five years’ experience with capsule endoscopy in a single center

Kav¹,

Bayraktar²

2009

WJG

View full text Add to dashboard Cite

Capsule endoscopy (CE) is a novel technology that facilitates highly effective and noninvasive imaging of the small bowel. Although its efficacy in the evaluation of obscure gastrointestinal bleeding (OGIB) has been proven in several trials, data on uses of CE in different small bowel diseases are rapidly accumulating in the literature, and it has been found to be superior to alternative diagnostic tools in a range of such diseases. Based on literature evidence, CE is recommended as a first-line investigation for OGIB after negative bidirectional endoscopy. CE has gained an important role in the diagnosis and follow-up of Crohn's disease and celiac disease and in the surveillance of small bowel tumors and polyps in selected patients. Capsule retention is the major complication, with a frequency of 1%-2%. The purpose of this review was to discuss the procedure, indications, contraindications and adverse effects associated with CE. We also review and share our five-year experience with CE in various small bowel diseases. The recently developed balloon-assisted enteroscopies have both diagnostic and therapeutic capability. At the present time, CE and balloon-assisted enteroscopies are complementary techniques in the diagnosis and management of small bowel diseases.

show abstract

“…CE underestimates the number of SB polyps and does not reliably detect large polyps [61] . Technical problems related to the battery and failure of image downloading are also reported.…”

Section: Complications Limitations and Safety Issues Of Capsule Endomentioning

confidence: 99%

“…The duodenum is a potential blind point of CE because the capsule passes quickly with tumble and results in inadequate examination. Wong et al [61] reported that CE underestimated the total number of polyps and did not reliably detect larger polyps in that portion.…”

Section: Small Bowel Tumors and Polypsmentioning

confidence: 99%

Five years’ experience with capsule endoscopy in a single center

Kav¹,

Bayraktar²

2009

WJG

View full text Add to dashboard Cite

show abstract

“…The same studies also emphasized that the duodenum is a potential blind point of CE because the capsule passes quickly with tumble and results in inadequate examination. CE underestimated the total number of polyps and did not reliably detect larger polyps in that portion (Wong et al, 2006). Nevertheless, more prospective studies with longer follow-up are required, to define the role of capsule endoscopy findings in the outcome of patients with gastrointestinal polyposis syndrome.…”

Section: Small Bowel Tumors and Polypsmentioning

confidence: 91%

Capsule Endoscopy: A Comprehensive Review

Jain¹,

Jain²

2011

New Techniques in Gastrointestinal Endoscopy

View full text Add to dashboard Cite

“…On the other hand, Wong and colleagues [98] from Utah found that CE underestimated the number of small bowel polyps and did not reliably detect large polyps. Additional studies are required before recommendations can be made.…”

Section: B C D Ementioning

confidence: 96%

Familial Adenomatous Polyposis

2006

Atlas of Genetic Diagnosis and Counseling

View full text Add to dashboard Cite

Familial adenomatous polyposis (FAP) is characterized by the development of many tens to thousands of adenomas in the rectum and colon during the second decade of life. FAP has an incidence at birth of about 1/8,300, it manifests equally in both sexes, and accounts for less than 1% of colorectal cancer (CRC) cases. In the European Union, prevalence has been estimated at 1/ 11,300-37,600. Most patients are asymptomatic for years until the adenomas are large and numerous, and cause rectal bleeding or even anemia, or cancer develops. Generally, cancers start to develop a decade after the appearance of the polyps. Nonspecific symptoms may include constipation or diarrhea, abdominal pain, palpable abdominal masses and weight loss. FAP may present with some extraintestinal manifestations such as osteomas, dental abnormalities (unerupted teeth, congenital absence of one or more teeth, supernumerary teeth, dentigerous cysts and odontomas), congenital hypertrophy of the retinal pigment epithelium (CHRPE), desmoid tumors, and extracolonic cancers (thyroid, liver, bile ducts and central nervous system). A less aggressive variant of FAP, attenuated FAP (AFAP), is characterized by fewer colorectal adenomatous polyps (usually 10 to 100), later age of adenoma appearance and a lower cancer risk. Some lesions (skull and mandible osteomas, dental abnormalities, and fibromas on the scalp, shoulders, arms and back) are indicative of the Gardner variant of FAP. Classic FAP is inherited in an autosomal dominant manner and results from a germline mutation in the adenomatous polyposis (APC) gene. Most patients (~70%) have a family history of colorectal polyps and cancer. In a subset of individuals, a MUTYH mutation causes a recessively inherited polyposis condition, MUTYH-associated polyposis (MAP), which is characterized by a slightly increased risk of developing CRC and polyps/adenomas in both the upper and lower gastrointestinal tract. Diagnosis is based on a suggestive family history, clinical findings, and large bowel endoscopy or full colonoscopy. Whenever possible, the clinical diagnosis should be confirmed by genetic testing. When the APC mutation in the family has been identified, genetic testing of all first-degree relatives should be performed. Presymptomatic and prenatal (amniocentesis and chorionic villous sampling), and even preimplantation genetic testing is possible. Referral to a geneticist or genetic counselor is mandatory. Differential diagnoses include other disorders causing multiple polyps (such as Peutz-Jeghers syndrome, familial juvenile polyps or hyperplastic polyposis, hereditary mixed polyposis syndromes, and Lynch syndrome). Cancer prevention and maintaining a good quality of life are the main goals of management and regular and systematic follow-up and supportive care should be offered to all patients. By the late teens or early twenties, colorectal cancer prophylactic surgery is advocated. The recommended alternatives are total proctocolectomy and ileoanal pouch or ileorectal anastomosis for AFAP. ...

show abstract

Video capsule endoscopy compared with standard endoscopy for the evaluation of small-bowel polyps in persons with familial adenomatous polyposis (with video)

Cited by 85 publications

References 38 publications

Five years’ experience with capsule endoscopy in a single center

Five years’ experience with capsule endoscopy in a single center

Capsule Endoscopy: A Comprehensive Review

Familial Adenomatous Polyposis

Contact Info

Product

Resources

About